发明名称 |
Ocular implant made by a double extrusion process |
摘要 |
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release. |
申请公布号 |
US9192511(B2) |
申请公布日期 |
2015.11.24 |
申请号 |
US201313922482 |
申请日期 |
2013.06.20 |
申请人 |
Allergan, Inc. |
发明人 |
Shiah Jane-Guo;Bhagat Rahul;Blanda Wendy M.;Nivaggioli Thierry;Peng Lin;Chou David;Weber David A. |
分类号 |
A61K9/00;A61K31/573;A61F9/00;A61K31/56;A61K9/16;A61K9/20 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
Wine Laura L.;German Joel B.;Condino Debra D. |
主权项 |
1. A bioerodible implant for treating a medical condition of the eye, the bioerodible implant comprising:
an active agent homogenously dispersed within a biodegradable polymer matrix, the biodegradable polymer matrix comprising a mixture of a first polymer and a second polymer, the first polymer being different than the second polymer; wherein the bioerodible implant is sized for implantation in an ocular region and the bioerodible implant comprises a double extruded rod. |
地址 |
Irvine CA US |